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Editors’ Note: In WriteClick this week, authors Hannawi
and Stevens respond to questions and comments about
their article, “Resting brain activity in disorders of
consciousness: A systematic review and meta-analysis.”
Drs. Shen et al. report that they were unable to reproduce
the authors’ analysis using the provided settings. Drs.
Garbarino and Sannita inquire whether viewing disorders
of consciousness as a continuum may help explain
heterogeneity in clinical measures. Author Schoenen
outlines additional statistical analyses performed on the
data presented in “Migraine prevention with a supraorbital
transcutaneous stimulator: A randomized controlled trial.”
An update related to this letter was published in the
December 1, 2015, print issue.
—Megan Alcauskas, MD, and Robert C. Griggs, MD
RESTING BRAIN ACTIVITY IN DISORDERS OF
CONSCIOUSNESS: A SYSTEMATIC REVIEW AND
META-ANALYSIS
Dongchao Shen, Linyi; Zhaobo Shen, Liying Cui,
Beijing, China: I read the article by Hannawi et al.1
on resting brain activity in disorders of consciousness.
Activation likelihood estimate (ALE) meta-analysis
allows the investigation of shared brain activation
across individual experiments by quantitatively iden-
tifying brain locations consistently associated with
different tasks or at resting state.2 When the datasets
are too small for the analysis, it might not find sig-
nificant convergence. The developers of GingerALE
have warned that this may be the case for datasets
smaller than 15 experiments.3 The authors’ ALE
meta-analysis consisted of 3–16 experiments. There-
fore, I conducted some parts of the analysis—vegetative
state (VS) vs healthy control (HC), minimally con-
scious state vs HC, patients with disorders of conscious-
ness (DOC) related to anoxia vs HC, and areas
that correlated with Coma Recovery Scale–Revised
score—according to the references and by the settings
that the authors provided. I found no clusters. Fur-
thermore, in the analysis of patients with DOC
related to anoxia vs HC, no useful coordinate was
provided in 1 of the 5 references that the authors
included with the ALE meta-analysis.4 I wonder if
the authors erred, used another model, or used
alternate GingerALE settings. It would be best if
the authors could provide the text files for each con-
trast that was imported into GingerALE, so the differ-
ences can be found.
Sergio Garbarino, Walter G. Sannita, Genoa, Italy:
Neural activity is reduced in DOC across a number of
brain structures that are thought to contribute to sus-
taining consciousness and are interfered with in these
conditions. The reduction is reportedly more pro-
nounced in VS compared with minimally conscious
state (MCS) and even more in coma compared to VS
and MCS.1,5 This observation is supported by elec-
trophysiologic findings,6 suggesting a possible patho-
physiologic continuum from coma to recovered
consciousness, of which coma and evolution into
the arousal/awareness dissociation characterizing VS
and MCS would be only transitional phases. The
functional core impairment was shared by all DOC
conditions in the meta-analyses by Hannawi et al.1
and Lutkenhoff et al.,5 but more complex patterns
were common, including associations of clinical
measures characterizing VS and MCS with tissue
atrophy in subcortical structures.1,5 Heterogeneities
in etiology or in the extension and severity of brain
damage (possibly crucial in this regard) would result
in preserved neural structures and residual resources7
and could question the boundaries between the con-
ventional DOC conditions. Fluctuations in brain
functional state are known to reflect the variations
of neuronal/non-neuronal biological parameters in
response to the functional or homeostatic require-
ments.8 The correlation between clinical responsive-
ness suggesting residual consciousness and the
sympathetic/parasympathetic balance indicates how
these end effects may be relevant and deserving of
systematic investigation in DOC.8
Author Response: Yousef Hannawi, Columbus,
OH; Robert D. Stevens, Baltimore:We thank Shen
et al. and Garbarino and Sannita for the comments on
our article.1
To answer the concerns raised by Shen et al., “too
few experiments” is a generic GingerALE software
message that appears when contrast analysis is per-
formed using less than 15 studies; this approach is
based on using within-group results.3 However, as
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detailed in our Methods and recommended by the
software developers when within-group effects are
rarely reported, we tested consistency of between-
group differences across studies.1,3 This approach
was employed successfully before and may yield find-
ings with a minimum of 2 inputs, with increased
generalizability of the results as the number of studies
increases.3,9
We also found no significant difference when we
performed contrast analysis of MCS vs VS.2 AU1Unlike
those of Shen et al., our datasets included additional
data that were obtained by contacting the correspond-
ing authors.1 Our findings are consistent with the
published literature, including the systematic review.1
We can only conclude that Dr. Shen has erred in
reproducing our analysis or did not follow the same
methods.
Finally, the coordinates were correctly selected for
the anoxia vs HC analysis, yet there was an error in
citation. The correct reference is Norton et al.,10
not Ovadia-Caro et al.4 Nevertheless, our results
and conclusions remain the same.
We agree with Drs. Garbarino and Sannita that
heterogeneities in etiology, severity, or distribution
of injury are a major constraint in any neuroimaging
study of patients with DOC. To minimize these ef-
fects on our meta-analysis, we performed separate
subgroup analyses of patients with VS, MCS, and ac-
cording to the underlying etiology of DOC (if
enough studies existed).1
We also agree that fluctuations in resting brain
activity may affect DOC classification at the individ-
ual level, which may change group level inferences.11
Thus, we investigated consistency of group level dif-
ferences across studies on a large scale. Included
studies used clear definitions of DOC as much as
possible. Our results matched the majority of the
studies that were included in our extensive system-
atic review.1 Overall, however, the impact of these
factors on the interpretation of functional activation
time courses in patients with DOC is not well-
understood and needs to be explored further. A
comprehensive and painstaking analysis would be
warranted to elucidate how low-frequency resting-
state fluctuations in patients with DOC might be
modulated by a range of neuronal and non-neuronal
variables, including the sympathetic/parasympa-
thetic balance.12
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MIGRAINE PREVENTION WITH A SUPRAORBITAL
TRANSCUTANEOUS STIMULATOR: A
RANDOMIZED CONTROLLED TRIAL
Jean E. Schoenen, Liege, Belgium: Additional sta-
tistical analyses were performed on the outcome
measures presented by Schoenen et al.1 to account
for covariates. A rank analysis of covariance was per-
formed, using the nonparametric Spearman rank
correlation coefficient.2 The results showed that
age and disease duration do not influence study out-
comes. However, the number of migraine days dur-
ing the 1-month baseline period had an influence on
the decrease in migraine days during the 3rd month
of treatment. In the original publication, the differ-
ence between verum and sham groups in the reduc-
tion of migraine days (respectively 229.7% and
24.9%) just missed the significance threshold
(p 5 0.054).1 However, when baseline migraine
days are considered as a covariate, this difference
becomes significant (p 5 0.044).
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This new analysis indicates that the beneficial
effect of Cefaly for migraine prevention might be
greater in patients with more frequent migraines,
which is of interest for clinical practice.
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